OrigiMedEnter platform

Product portfolio

One company. Four independent review surfaces.

The portfolio is organised by the question each product helps examine. It is not a shared technical workflow and does not imply automatic transfer of patient data.

Molecular reviewIndependent product · account required

CUPAI

Could the molecular evidence support a different tissue-of-origin hypothesis?

A molecular second-opinion workflow for reviewing an NGS report across a defined model scope.

BoundaryResearch use only. Not for clinical diagnosis.
Review scope and access
Fusion evidenceIndependent product · public positioning under review

VeraFusionDx

What structural and evidence context is available for a reported fusion?

A structured review surface for fusion coordinates, reading frame, protein context and cited evidence.

BoundaryPublic intended-use wording is under formal owner review. Confirm findings with validated clinical methods.
Review scope and access
Tissue triage researchLocal validation · no public product access

PathAIFusion

Could an H&E slide support prioritising confirmatory molecular testing?

An investigational image-analysis workflow for research triage before confirmatory testing.

BoundaryResearch use only. Not an IVD and cannot rule out a fusion.
Review scope and access
Patient preparationIndependent product · account required

SmartMTB 2.0

How can complex oncology information be organised for a clinician conversation?

A patient-facing workspace for organising questions, visit preparation and explanatory materials.

BoundaryInformational AI tool. Not a medical device, diagnosis or treatment recommendation.
Review scope and access